Prognosis
Vaccine Makers Warn Bottlenecks, Nationalism Threaten Production
- Shortages of skilled labor, raw materials imperil production
- Moderna, Glaxo executives discuss problems at industry summit
This article is for subscribers only.
Moderna Inc. and GlaxoSmithKline Plc are among a group of drugmakers calling for countries to remove trade barriers related to Covid-19 vaccines amid worsening shortages of basic products needed to manufacture shots globally.
The industry is highlighting that the world needs more raw materials, including lipids used in the messenger RNA vaccines, tubing and plastic bags, according to a press briefing Friday on Covid-19 manufacturing led by the International Federation of Pharmaceutical Manufacturers and Associations. Panelists criticized the use of the U.S. Defense Production Act to protect U.S. supplies, as that’s aggravating the problem.